These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 10628897)

  • 1. Pharmacokinetics and clinical effectiveness of methylphenidate.
    Kimko HC; Cross JT; Abernethy DR
    Clin Pharmacokinet; 1999 Dec; 37(6):457-70. PubMed ID: 10628897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylphenidate and its isomers: their role in the treatment of attention-deficit hyperactivity disorder using a transdermal delivery system.
    Heal DJ; Pierce DM
    CNS Drugs; 2006; 20(9):713-38. PubMed ID: 16953648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose pharmacokinetics of NWP06, an extended-release methylphenidate suspension, in children and adolescents with ADHD.
    Childress AC; Sallee FR; Berry SA
    Postgrad Med; 2011 Sep; 123(5):80-8. PubMed ID: 21904089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder.
    Quinn D; Wigal S; Swanson J; Hirsch S; Ottolini Y; Dariani M; Roffman M; Zeldis J; Cooper T
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1422-9. PubMed ID: 15502602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder.
    Stevenson RD; Wolraich ML
    Pediatr Clin North Am; 1989 Oct; 36(5):1183-97. PubMed ID: 2677938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does chirality matter? pharmacodynamics of enantiomers of methylphenidate in patients with attention-deficit/hyperactivity disorder.
    Quinn D
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S62-6. PubMed ID: 18480679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylphenidate blood levels and therapeutic response in children with attention-deficit hyperactivity disorder: I. Effects of different dosing regimens.
    Teicher MH; Polcari A; Foley M; Valente E; McGreenery CE; Chang WW; McKay G; Midha KK
    J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):416-31. PubMed ID: 16958567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic variability of long-acting stimulants in the treatment of children and adults with attention-deficit hyperactivity disorder.
    Ermer JC; Adeyi BA; Pucci ML
    CNS Drugs; 2010 Dec; 24(12):1009-25. PubMed ID: 21090837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic considerations in the treatment of attention-deficit hyperactivity disorder with methylphenidate.
    Wolraich ML; Doffing MA
    CNS Drugs; 2004; 18(4):243-50. PubMed ID: 15015904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Evaluation Approach for the Performance of Dosing Regimens in Attention-Deficit/Hyperactivity Disorder Treatment.
    Bonnefois G; Robaey P; Barrière O; Li J; Nekka F
    J Child Adolesc Psychopharmacol; 2017 May; 27(4):320-331. PubMed ID: 28165318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulations.
    Childress AC; Komolova M; Sallee FR
    Expert Opin Drug Metab Toxicol; 2019 Nov; 15(11):937-974. PubMed ID: 31581854
    [No Abstract]   [Full Text] [Related]  

  • 12. New formulations of stimulants for attention-deficit hyperactivity disorder: therapeutic potential.
    Connor DF; Steingard RJ
    CNS Drugs; 2004; 18(14):1011-30. PubMed ID: 15584770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder.
    Wigal S; Swanson JM; Feifel D; Sangal RB; Elia J; Casat CD; Zeldis JB; Conners CK
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1406-14. PubMed ID: 15502600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of methylphenidate transdermal system (MTS): results from a laboratory classroom study.
    Pierce D; Dixon CM; Wigal SB; McGough JJ
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):355-64. PubMed ID: 18759645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose pharmacokinetics of multilayer-release methylphenidate and immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.
    Quinn D; Bode T; Reiz JL; Donnelly GA; Darke AC
    J Clin Pharmacol; 2007 Jun; 47(6):760-6. PubMed ID: 17395894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic properties of stimulants: implications for the design of new treatments for ADHD.
    Swanson JM; Volkow ND
    Behav Brain Res; 2002 Mar; 130(1-2):73-8. PubMed ID: 11864720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and therapeutic effect of OROS methylphenidate under different breakfast conditions in children with attention-deficit/hyperactivity disorder.
    Wigal SB; Gupta S; Heverin E; Starr HL
    J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):255-63. PubMed ID: 21663428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The medical treatment of attention deficit hyperactivity disorder (ADHD) with amphetamines in children and adolescents].
    Frölich J; Banaschewski T; Spanagel R; Döpfner M; Lehmkuhl G
    Z Kinder Jugendpsychiatr Psychother; 2012 Sep; 40(5):287-99; quiz 299-300. PubMed ID: 22869222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain kinetics of methylphenidate (Ritalin) enantiomers after oral administration.
    Ding YS; Gatley SJ; Thanos PK; Shea C; Garza V; Xu Y; Carter P; King P; Warner D; Taintor NB; Park DJ; Pyatt B; Fowler JS; Volkow ND
    Synapse; 2004 Sep; 53(3):168-75. PubMed ID: 15236349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of methylphenidate: insights from PET imaging studies.
    Volkow ND; Fowler JS; Wang G; Ding Y; Gatley SJ
    J Atten Disord; 2002; 6 Suppl 1():S31-43. PubMed ID: 12685517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.